Triple Ring will be present at the 2025 JP Morgan week events in San Francisco, California. With our headquarters in nearby Silicon Valley, Triple Ring’s executives and managers always make time to meet the international crowd that converges on Union Square. Ryan McGuinness, Joe Heanue, and many others will be attending meetings and receptions all week.

This year we are excited to be connecting with large MedTech and Life Science companies and Venture Investors to discuss our Corporate Venture Building partnerships. At Triple Ring, Corporate Venture Building is the practice of building a separate venture from scratch – A new brand, team, program, revenue stream, or P&L to target untapped opportunity spaces – new customer segments, technologies or capabilities – outside of the core existing business. These efforts can be a fully internal, adjacent, fully external, or hybrid.

Our activities include market analysis, product ideation, regulatory and clinical strategy, technology and IP landscaping, innovation workshops, organization/program design and implementation, incubation and accelerator facilities, infrastructure, and equipment through our Agility Labs business, and full service product development through commercialization. Partnership structures often include co-investment ranging from “shared risk” to full spin-out/spin-in. We also have had great success with non-dilutive funding.

Feel free to contact us to arrange a meet up during the week.

Triple Ring’s Joe Heanue will be participating in a discussion panel Thursday, September 12 at the Hynes Convention Center in Boston. The session, Unveiling CVC Investment Strategies in Digital Health & MedTech, includes seasoned funding experts from the Digital Health and MedTech industries. The panel, moderated by Vijay Kori, also includes Suzie Yoon, Investment Principal at Takeda Digital Ventures; Carrie Hurwitz Williams, VP and Partner at McKesson Ventures;  John Pavletic, Executive Director at Lilly Ventures; and Alex de Winter, VP of New Ventures at Danaher Ventures.

During the session, panelists will dive into a range of timely and important topics centered on Corporate Venture Capital and the factors that drive their investment decisions. They will discuss which areas in Digital Health and MedTech are primed for growth, how they strike the right balance between strategic alignment and financial interests and analyze the current valuation environment.

Triple Ring team members, Nick Hawson, Kevin Limtao, and Ryan McGuinness will be attending the event as well. We look forward to discussing MedTech innovation and how Triple Ring supports many of the world’s best companies as they drive new products to market.  If you’d like to meet with us at the conference or around Boston during the week of September 9, don’t hesitate to reach out.